NU 664C ANXIETY DISORDERS AND
THEIR TREATMENTS EXAM
QUESTIONS WITH CORRECT
SOLUTIONS||100% GUARANTEED
PASS||UPDATED 2026/2027
SYLLABUS||ALREADY GRADED
A+||<<LATEST VERSION>>
Which of the following characteristics are critical factors to evaluate in light of a
client's potential for suicide? - ANSWER ✓ Hopelessness and helplessness
Which of the following is a protective factor for the risk of suicide? - ANSWER
✓ Having a sense of responsibility for one's spouse or children
Having good social standing in the community
Having an IQ over 120
Which of the following PMHNP activities may contribute to successfully
accomplishing the Health People 2020 goals? - ANSWER ✓ Reach educators
about suicide screening and prevention at the local high school
Use the Beck Depression Inventory (BDI) i private practice
Provide education to high school students and their parents about eating disorders
Write a local senator about current NP practice restrictions
Which one of the following is a self-administered rating scale in psychiatry? -
ANSWER ✓ Beck Depression Inventory (BDI)
Women are twice as likely to become depressed but men are more at risk for
suicide. - ANSWER ✓ True
Genetic variations associated with panic disorder. - ANSWER ✓ Single
Nucleotide Polymorphisms (SNPs)
,Process influenced by genes in the frontal cortex. - ANSWER ✓ mRNA
Expression
Collaboration identifying potential novel risk genes. - ANSWER ✓ Psychiatric
Genetics Consortium
Interactions between genetic predispositions and life events. - ANSWER ✓ Gene-
Environment Interactions
Study of gene expression changes without DNA alteration. - ANSWER ✓
Epigenetics
Research using brain imaging to study anxiety. - ANSWER ✓ Neuroimaging
Studies
Brain region associated with fear and anxiety. - ANSWER ✓ Amygdala
Brain area implicated in memory and anxiety regulation. - ANSWER ✓
Hippocampus
Brain areas showing abnormalities in panic disorder. - ANSWER ✓
Parahippocampal Regions
Structural brain changes linked to anxiety disorders. - ANSWER ✓ Gray Matter
Abnormalities
Physiological response to perceived threats or stress. - ANSWER ✓ Fight-or-
Flight Reaction
Long-term stress response leading to system alterations. - ANSWER ✓ Chronic
Activation
Neurotransmitters involved in anxiety mechanisms. - ANSWER ✓ Monoamines
Hormonal system regulating stress response. - ANSWER ✓ HPA Axis
, Hormone involved in stress and anxiety responses. - ANSWER ✓ Corticotropin-
Releasing Hormone (CRH)
Small protein-like molecules influencing neurotransmission. - ANSWER ✓
Neuropeptides
Neural pathways involved in fear processing. - ANSWER ✓ Fear Circuitry
Biochemical pathways influencing anxiety disorders. - ANSWER ✓
Neurochemical Systems
Involved in unrestrained, excessive system activation associated with anxiety
disorders. - ANSWER ✓ Noradrenergic system
Dysregulated function with excessive cortisol release and abnormal feedback in
some anxiety disorders. - ANSWER ✓ Hypothalamic-pituitary-adrenal (HPA)
axis
Persistently increased concentration linked to anxiety disorders; CRH-1 receptor
antagonists have failed to demonstrate efficacy in clinical trials. - ANSWER ✓
Corticotropin-releasing hormone (CRH)
First-line therapy for anxiety disorders, along with SSRIs. - ANSWER ✓ SNRIs
Used for performance anxiety. - ANSWER ✓ Propranolol
Under study for generalized anxiety disorder (GAD). - ANSWER ✓ Mifepristone
Abnormal peripheral levels found in panic disorder (PD), possibly also in GAD
and social anxiety disorder (SAD). - ANSWER ✓ Neurosteroids
Single nucleotide polymorphism in AVP V1b receptor gene linked to panic
disorder. - ANSWER ✓ Arginine vasopressin (AVP)
Bupropion is an NDRI used primarily to treat depression, sometimes as an adjunct
for anxiety disorders. - ANSWER ✓ Dopaminergic system
First-line therapy for anxiety disorders. - ANSWER ✓ Serotonergic system
THEIR TREATMENTS EXAM
QUESTIONS WITH CORRECT
SOLUTIONS||100% GUARANTEED
PASS||UPDATED 2026/2027
SYLLABUS||ALREADY GRADED
A+||<<LATEST VERSION>>
Which of the following characteristics are critical factors to evaluate in light of a
client's potential for suicide? - ANSWER ✓ Hopelessness and helplessness
Which of the following is a protective factor for the risk of suicide? - ANSWER
✓ Having a sense of responsibility for one's spouse or children
Having good social standing in the community
Having an IQ over 120
Which of the following PMHNP activities may contribute to successfully
accomplishing the Health People 2020 goals? - ANSWER ✓ Reach educators
about suicide screening and prevention at the local high school
Use the Beck Depression Inventory (BDI) i private practice
Provide education to high school students and their parents about eating disorders
Write a local senator about current NP practice restrictions
Which one of the following is a self-administered rating scale in psychiatry? -
ANSWER ✓ Beck Depression Inventory (BDI)
Women are twice as likely to become depressed but men are more at risk for
suicide. - ANSWER ✓ True
Genetic variations associated with panic disorder. - ANSWER ✓ Single
Nucleotide Polymorphisms (SNPs)
,Process influenced by genes in the frontal cortex. - ANSWER ✓ mRNA
Expression
Collaboration identifying potential novel risk genes. - ANSWER ✓ Psychiatric
Genetics Consortium
Interactions between genetic predispositions and life events. - ANSWER ✓ Gene-
Environment Interactions
Study of gene expression changes without DNA alteration. - ANSWER ✓
Epigenetics
Research using brain imaging to study anxiety. - ANSWER ✓ Neuroimaging
Studies
Brain region associated with fear and anxiety. - ANSWER ✓ Amygdala
Brain area implicated in memory and anxiety regulation. - ANSWER ✓
Hippocampus
Brain areas showing abnormalities in panic disorder. - ANSWER ✓
Parahippocampal Regions
Structural brain changes linked to anxiety disorders. - ANSWER ✓ Gray Matter
Abnormalities
Physiological response to perceived threats or stress. - ANSWER ✓ Fight-or-
Flight Reaction
Long-term stress response leading to system alterations. - ANSWER ✓ Chronic
Activation
Neurotransmitters involved in anxiety mechanisms. - ANSWER ✓ Monoamines
Hormonal system regulating stress response. - ANSWER ✓ HPA Axis
, Hormone involved in stress and anxiety responses. - ANSWER ✓ Corticotropin-
Releasing Hormone (CRH)
Small protein-like molecules influencing neurotransmission. - ANSWER ✓
Neuropeptides
Neural pathways involved in fear processing. - ANSWER ✓ Fear Circuitry
Biochemical pathways influencing anxiety disorders. - ANSWER ✓
Neurochemical Systems
Involved in unrestrained, excessive system activation associated with anxiety
disorders. - ANSWER ✓ Noradrenergic system
Dysregulated function with excessive cortisol release and abnormal feedback in
some anxiety disorders. - ANSWER ✓ Hypothalamic-pituitary-adrenal (HPA)
axis
Persistently increased concentration linked to anxiety disorders; CRH-1 receptor
antagonists have failed to demonstrate efficacy in clinical trials. - ANSWER ✓
Corticotropin-releasing hormone (CRH)
First-line therapy for anxiety disorders, along with SSRIs. - ANSWER ✓ SNRIs
Used for performance anxiety. - ANSWER ✓ Propranolol
Under study for generalized anxiety disorder (GAD). - ANSWER ✓ Mifepristone
Abnormal peripheral levels found in panic disorder (PD), possibly also in GAD
and social anxiety disorder (SAD). - ANSWER ✓ Neurosteroids
Single nucleotide polymorphism in AVP V1b receptor gene linked to panic
disorder. - ANSWER ✓ Arginine vasopressin (AVP)
Bupropion is an NDRI used primarily to treat depression, sometimes as an adjunct
for anxiety disorders. - ANSWER ✓ Dopaminergic system
First-line therapy for anxiety disorders. - ANSWER ✓ Serotonergic system
